Emily Ethridge covers health care policy as a staff writer for CQ Roll Call. Prior to that, she covered several committees, the Senate floor, and the House floor as part of CQ's legislative action team. She also wrote for a newsletter covering the prescription drug and medical device industries.
A native of Charlotte, North Carolina, Emily has lived in the District of Columbia since graduating from the Johns Hopkins University with a degree in Writing Seminars. She currently lives in the Logan Circle neighborhood and enjoys trying to keep up with her fellow runners at CQ Roll Call.
One of the Food and Drug Administration’s newest tools in trying to protect consumers from counterfeit or contaminated drugs is a system to enhance tracking of products throughout the distribution chain.
The Food and Drug Administration is tasked with overseeing the safety and quality of most of the food, medical devices, drugs, biological products, vaccines and cosmetics in the United States. But every year, more and more of those products come into the country from other nations.
With all the enthusiasm and energy to get rid of the flawed system that Medicare uses to pay physicians, why isn’t it gone yet?
Provider groups have often raised the specter of physicians shutting their door to Medicare patients as a possible consequence of the perpetually looming Medicare physician payment cuts. But administration officials and the independent Medicare Payment Advisory Committee say the problem is not as dire as some suggest.
In 2012, lawmakers hailed legislation that outlawed the sale of 26 designer drugs — substances meant to mimic the properties of illegal drugs such as marijuana or cocaine. The synthetics have been linked to incidences of violence, overdoses and suicides.
The prosecution of manufacturers and distributors of synthetic drugs presents different challenges from going after typical drug dealers, law enforcement officials say.
With the government days away from shutting down, and Republicans still searching for votes on a measure to raise the debt ceiling, House Majority Leader Eric Cantor took some time Thursday to focus on what’s really important: the children.
Senators hope that they will soon get a chance to quickly pass legislation that would give the Food and Drug Administration more authority over compounding pharmacies. For months, lawmakers in both chambers have been working on the best way to respond to last year’s fatal fungal meningitis outbreak linked to a contaminated compounded drug.
Although lawmakers are working to increase oversight of some compounding pharmacies, they agree that the practice of traditional compounding serves an important purpose and should be protected.
Beachgoers reaching for the sunscreen this summer may notice some new labels on the bottles, including warnings that the product may not protect against skin cancer.
Salt may be at the heart of a dietary disagreement, but it’s also the main ingredient in a billion-dollar American industry.
A month after House Republican leaders were forced to pull an unpopular Obamacare revision from the House floor, bill sponsor Rep. Joe Pitts, R-Pa., said he expects to see a modified version under consideration again in “a couple of weeks.”
The Food and Drug Administration is able to do its work in part because of a symbiotic relationship with the industries it regulates. But recently that relationship has been knocked off balance.
Conservative groups and some lawmakers are pushing Republicans to focus on legislation that would ruin the health care law’s implementation — a strategy that complicates efforts to pass any other kind of health care bill.
Lawmakers and congressional staff members are concerned about whether the federal government will continue to pay part of their premiums as they move to buying insurance through the exchanges next year.
Health care stakeholders complain that some of Medicare’s benefit structure is still stuck in the 1960s, when the program was created. As lawmakers search for ways to reduce government spending, many are looking to find savings by bringing all of Medicare into the current century.
Although the Senate-adopted budget resolution upholds the 2010 health care overhaul, Republicans added several repeal and oversight provisions through amendment votes on the floor and in committee.
Observers watching the Senate on the afternoon of March 13 could be forgiven for feeling a little bit of déjà vu. Senators were once again voting on a motion to try to disable the 2010 health care overhaul — this time by delaying any funding for the law, courtesy of an amendment from Republican freshman Ted Cruz of Texas.
The House Republican budget will balance the budget over 10 years in part by cutting spending by about $5 trillion and turning Medicare into a premium support program, Rep. Paul D. Ryan said Sunday.
Marilyn Tavenner has another shot to be confirmed as leader of the Centers for Medicare and Medicaid Services, but getting there will require defending the 2010 health care law to Senate Republicans.
An expensive, high-end cigar selected from one of the best boutique manufacturers. A small grape-flavored Swisher Sweet bought in a pack at a gas station for less than $1 each. Are they the same thing?
The retirement of Chairman Tom Harkin in 2014 means the Senate Health, Education, Labor and Pensions Committee is likely to wind up with a different kind of leader.
The bill to avert the fiscal cliff would repeal a suspended program in the 2010 health care law that has long been targeted by Republicans.
The Senate-passed fiscal cliff bill would block for one year a scheduled 27 percent cut in reimbursements for Medicare physicians, paid for by familiar cuts and adjustments to other provider payments.
The fiscal cliff legislation worked out Monday contains a one-year payment patch for physicians who treat Medicare patients, paid for by health care offsets, according to a Senate Democratic aide.